Company: HUM
Filing Date: 2025-03-31
Form Type: 8-K
Source: 0001628280-25-015646
Chunk: 0

Company: HUMANA INC
Filing Date: 2025-03-31
Form: 8-K
Item: Item 1.01
Chunk 0
---
Item 1.01. Entry into a Material Definitive Agreement.

Underwriting Agreement

On March 26, 2025, Humana Inc. (the “ Company”) entered into an underwriting agreement (the “ Underwriting Agreement”) with J. P. Morgan Securities LLC and Barclays Capital Inc., as representatives of the several underwriters (together, the “ Underwriters”), pursuant to which the Company agreed to issue and sell to the Underwriters an additional $250 million aggregate principal amount of its 5.375% Senior Notes due 2031 (the “ Additional 2031 Notes”), in accordance with the terms and conditions set forth in the Underwriting Agreement. The Additional 2031 Notes are an additional issuance of the 5.375% Senior Notes due 2031 that the Company issued in an aggregate principal amount of $1.25 billion on March 13, 2024 (the “ Existing 2031 Notes” and, together with the Additional 2031 Notes, the “ Notes”). The Additional 2031 Notes are fungible with the Existing 2031 Notes and form a single series with the Existing 2031 Notes. The Additional 2031 Notes have terms that are identical to the terms of the Existing 2031 Notes (except for the issuance date and issuance price) and have the same ISIN and CUSIP numbers as the Existing 2031 Notes. The Additional 2031 Notes were sold at a public offering price of 99.941% of the aggregate principal amount thereof, plus accrued interest from October 15, 2024 (the most recent interest payment date) to but excluding the settlement date. Following the completion of the offering, together with the previously issued $1.25 billion in aggregate principal amount of the Existing 2031 Notes, the total outstanding aggregate principal amount of the Notes is $1.5 billion.

The sale of the Additional 2031 Notes has been registered with the Securities and Exchange Commission (the “ Commission”) in a registration statement on Form S-3, File No. 333-277734 (the “ Registration Statement”). The terms of the Additional 2031 Notes are described in the Company’s Prospectus dated March 7, 2024, as supplemented by a final Prospectus Supplement dated March 26, 2025 as filed with the Commission on March 27, 2025, pursuant to Rule 424(b)(5) under the Securities Act of 1933, as amended.

The Underwriters and